Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493)
Jade Maillou, Reilly Pidgeon, Diogjena Katerina Prifti, Meriem Messaoudene, Sreya Duttagupta, Myriam Benlaïfaoui, Yongjia Hu, A. A. Filin, Mayra Ponce, Wiam Belkaïd, Julie Malo, Guido Guido Kroemer, Sylvère Durand, Olivier Barbier, Nathalie Daaboul, Normand Blais, Mustapha Thefe, Marie Florescu, Rahima Jamal, Wilson H. Miller, Antoine Desîlets, Bastien Castagner, Arielle Elkrief, Bertrand Routy (2025). Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493). , 85(8_Supplement_1), DOI: https://doi.org/10.1158/1538-7445.am2025-2223.
Article316 days ago1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate)
Arielle Elkrief, Siddhartha P. Duttagupta, R. Jamal, Nicolas Marcoux, Antoine Desîlets, Meriem Messaoudene, Catalin Mihalcioiu, Sylvère Durand, M. Tehfe, N. Blais, Sioned Owen, J. Raphael, John Lenehan, Seema Nair Parvathy, L. Derosa, L. Zitvogel, Guido Guido Kroemer, Michael H. Silverman, Saman Maleki Vareki, Bertrand Routy (2024). 1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate). , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.1126.
Article316 days agoBenzodiazepines compromise the outcome of cancer immunotherapy
Léa Montégut, Lisa Derosa, Meriem Messaoudene, Hui Chen, Flavia Lambertucci, Bertrand Routy, Laurence Zitvogel, Isabel Martins, Guido Guido Kroemer (2024). Benzodiazepines compromise the outcome of cancer immunotherapy. , 13(1), DOI: https://doi.org/10.1080/2162402x.2024.2413719.
Article316 days agoTable S1 from Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa, Bertrand Routy, Antoine Desîlets, Romain Daillère, Safae Terrisse, Guido Guido Kroemer, Laurence Zitvogel (2023). Table S1 from Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?. , DOI: https://doi.org/10.1158/2159-8290.22540048.v1.
Preprint316 days agoTable S1 from Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa, Bertrand Routy, Antoine Desîlets, Romain Daillère, Safae Terrisse, Guido Guido Kroemer, Laurence Zitvogel (2023). Table S1 from Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?. , DOI: https://doi.org/10.1158/2159-8290.22540048.
Preprint316 days ago